Mahdi Taha, DO, FACOI, FACP
Dr. Mahdi Taha is a hematologist and medical oncologist with Florida Cancer Specialists in Palm Beach County.
Dr. Taha earned his medical degree from New York College of Osteopathic Medicine in Old Westbury, New York. After completing his residency in Internal Medicine at the Oklahoma State University Medical Center in Tulsa, he was awarded a fellowship at Cancer Treatment Centers of America through Oklahoma State University, where he was named medical oncology Chief Fellow.
Prior to joining FCS in 2020, Dr. Taha volunteered for the American Red Cross Haiti Disaster Relief, where he cared for patients in Port-Au-Prince and at the World Trade Center during the tragic 9/11 catastrophe. He was also an adjunct clinical professor for the Morehouse School of Medicine in Atlanta, Georgia and the lead medical oncologist at the Cancer Treatment Centers of America and Research Center.
In 2019, Dr. Taha received the Georgia Trend Magazine “40 Under 40 for 2019” Award and the Castle Connolly Top Doctor Award each year since 2017. He was also awarded the prestigious Atlanta Magazines’ “Top 500 Most Influential People in Atlanta” in 2020.
Dr. Taha has a strong interest in research with a focus in Thoracic Oncology, Head and Neck Cancer, ImmunoOncology, Genitourinary Oncology including prostate cancer, urothelial carcinoma and renal cell carcinoma, as well as skin cancers and breast cancer.
He has served on various research committees and participated as principal investigator within several clinical trial studies and serves as Director of Oncology at Delray Medical Center.
Dr. Taha has given international presentations at conferences such as the European Medical Society of Oncology, The International World Lung Conference and ACOI National Convention Case Presentation in San Antonio, Texas, which won the First Place, National Award.
Dr. Taha serves as a medical consultant nationally and internationally for numerous pharmaceutical and genomic projects. He has provided medical correspondence and been featured on television networks, including CBS, FOX, NBC and Telemundo.
- Hematology
- Medical Oncology
- English
Medical School
New York College of Osteopathic Medicine, Old Westbury, NY
Residency
Oklahoma State University Medical Center, Tulsa, OK
Fellowship
Oklahoma State University/Cancer Treatment Centers of America
Fellow of American College of Osteopathic Internists
Fellow of American College of Physicians
Board Certified
Medical Oncology
Internal Medicine
Honors & Achievements
Boca Raton Observer – 2021, 2022, 2023
Georgia Trend Magazine Top 40 Under 40 Award – 2020
Georgia Trend Top 500 Most Influential People in Georgia – 2020
Atlanta Magazine Top Doctor – 2019, 2020
Professional Affiliations
Florida Atlantic University – Charles E. Schmidt College of Medicine Associate Clinical Professor
Community
Global Key Opinion Leader Renal Cell Carcinoma
Global Key Opinion Leader Prostate Carcinoma
National Key Opinion Leader Thoracic Oncology
National Key Opinion Leader Head and Neck Cancer
FCS Medical Oncologist and Hematologist Mahdi Taha spoke to Fox 29 News on PFAS, commonly known as “Forever Chemicals” and the impact they can have on your health and how you can limit your exposure to these manmade chemicals. For more information, please visit www.epa.gov
Dr. Taha is featured in this story about a new prostate cancer treatment available in south Florida hospital is helping patients in Southern Palm Beach County feel more like themselves while fighting the disease.
Prostate cancer is the most common cancer in American men – with 1 out of 9 men being diagnosed in their lifetime. FCS medical oncologist and hematologist, Dr. Mahdi Taha, talks about understanding and recognizing your risk factors as well screening guideline recommendations in a WPTV segment for Mens Health Month.
One in eight American males will be diagnosed with prostate cancer in their lifetime, so it’s important to know the facts. Florida Cancer Specialists medical oncologists Dr. Barry Berman and Dr. Mahdi Taha discuss who is most at risk and the recommended screenings, as well as the individualized treatments available. FCS offers clinical trials as an added option for achieving the best possible outcomes.
Expert notes on Colorectal Cancer.